CARGO Total Other Income Expense Net vs Ebitda Analysis
| CRGX Stock | 15.73 0.09 0.57% |
CARGO Therapeutics, financial indicator trend analysis is way more than just evaluating CARGO Therapeutics, prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CARGO Therapeutics, is a good investment. Please check the relationship between CARGO Therapeutics, Total Other Income Expense Net and its Ebitda accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CARGO Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Total Other Income Expense Net vs Ebitda
Total Other Income Expense Net vs Ebitda Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CARGO Therapeutics, Total Other Income Expense Net account and Ebitda. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between CARGO Therapeutics,'s Total Other Income Expense Net and Ebitda is 0.46. Overlapping area represents the amount of variation of Total Other Income Expense Net that can explain the historical movement of Ebitda in the same time period over historical financial statements of CARGO Therapeutics, Common, assuming nothing else is changed. The correlation between historical values of CARGO Therapeutics,'s Total Other Income Expense Net and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Other Income Expense Net of CARGO Therapeutics, Common are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Total Other Income Expense Net i.e., CARGO Therapeutics,'s Total Other Income Expense Net and Ebitda go up and down completely randomly.
Correlation Coefficient | 0.46 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Total Other Income Expense Net
Ebitda
Most indicators from CARGO Therapeutics,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CARGO Therapeutics, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CARGO Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. At this time, CARGO Therapeutics,'s Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 521.4 M in 2024, whereas Enterprise Value Over EBITDA is likely to drop (6.51) in 2024.
| 2010 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 6.0M | 34.8M | 96.7M | 50.4M | Cost Of Revenue | 147K | 1.4M | 3.7M | 1.9M |
CARGO Therapeutics, fundamental ratios Correlations
Click cells to compare fundamentals
CARGO Therapeutics, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CARGO Stock Analysis
When running CARGO Therapeutics,'s price analysis, check to measure CARGO Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CARGO Therapeutics, is operating at the current time. Most of CARGO Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of CARGO Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CARGO Therapeutics,'s price. Additionally, you may evaluate how the addition of CARGO Therapeutics, to your portfolios can decrease your overall portfolio volatility.